Emerging Therapies Redefining the HR+/HER2- Breast Cancer Treatment...

added blog Health

2025-12-23 19:29:53 -

Emerging Therapies Redefining the HR+/HER2- Breast Cancer Treatment Landscape

The treatment paradigm for HR+/HER2- breast cancer is evolving rapidly as innovative therapies advance through late-stage trials and enter clinical practice. Long-standing reliance on endocrine therapies and CDK4/6 inhibitors is being challenged by resistance and unmet patient needs. As a result, next-generation solutions such as oral SERDs, PROTACs, and novel antibody-drug conjugates are...

0 Comments 0 Shares 287 Views 0 Reviews